Christophe Bourgoin, Ph.D.
About Christophe Bourgoin, Ph.D.
Christophe Bourgoin, Ph.D., is the Head of Global Clinical Trial Strategy & Operations for Hem/Onc Early Clinical Development at Bristol Myers Squibb in Summit, New Jersey. He has extensive experience in managing clinical trials across North America and Europe, with a deep understanding of oncology, gene therapy, and intensive care.
Title and Company
Christophe Bourgoin, Ph.D., is currently the Head of Global Clinical Trial Strategy & Operations for Hematology/Oncology Early Clinical Development at Bristol Myers Squibb, located in Summit, New Jersey, United States.
Previous Roles at Celgene Corporation
Christophe Bourgoin held several key positions at Celgene Corporation between 2012 and 2020. He served as Senior Director, Clinical Operations, Early Development in Summit, New Jersey from 2015 to 2020. Prior to that, he worked at the Celgene Institute for Translational Research Europe in Seville, Spain, as an Associate Director, Clinical Research from 2013 to 2015, and as a Senior Study Manager from 2012 to 2013.
Experience at ORION Clinical Services
Before his tenure at Celgene Corporation, Christophe Bourgoin was pivotal in several roles at ORION Clinical Services. From 2009 to 2011, he was Associate Director of Clinical Operations in Greater London, UK. He managed complex clinical trials as Project Manager and Senior Project Manager from 2006 to 2009 in Princeton, NJ, and Le Plessis Robinson, France. He began his career with ORION Clinical Services as a Clinical Research Associate from 2003 to 2006.
Education and Academic Background
Christophe Bourgoin completed his Ph.D. in Biological Therapies at Université Denis Diderot (Paris VII) from 2000 to 2003, after achieving an MSc in the same field from 1999 to 2000. He earned a BSc in Biochemistry from Sorbonne Université, where he studied from 1996 to 1999. His academic background laid a solid foundation for his extensive career in clinical research and operations.
Global Experience in Clinical Trial Management
Christophe Bourgoin has broad experience in managing clinical trials across several continents, including North America and Europe. He has worked in four countries: the USA, France, the UK, and Spain. This international experience has provided him with a deep understanding of various regulatory environments and operational strategies, enhancing his ability to conduct effective and compliant clinical trials.
Specialized Expertise and Focus Areas
Christophe Bourgoin has a comprehensive background in oncology, with specific expertise in prostate cancer, glioblastoma, metastatic breast cancer, osteosarcoma, NSCLC, MDS, myelofibrosis, non-Hodgkin lymphoma, multiple myeloma, CLL, SLL, all comer solid tumors, pancreatic cancer, head and neck cancer, and neuroendocrine carcinomas. Additionally, he is well-versed in gene therapy, intensive care, ventilation-acquired pneumonia, lung transplants, rheumatoid arthritis, radiology (CT scan contrast agents), and pediatric vaccines.